Capital Research Global Investors Takeda Pharmaceutical CO LTD Transaction History
Capital Research Global Investors
- $466 Billion
- Q4 2024
A detailed history of Capital Research Global Investors transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Capital Research Global Investors holds 13,162,513 shares of TAK stock, worth $185 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
13,162,513
Previous 13,137,204
0.19%
Holding current value
$185 Million
Previous $187 Million
6.65%
% of portfolio
0.04%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Morgan Stanley New York, NY5.6MShares$78.7 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$65.1 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$59.3 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$45.6 Million0.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$43.3 Million0.06% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.7B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...